Genomics Drugs Pharmacogenomics, Gluucose, Metabolic Pathways, Genomics, Prognostic Genotype

Scholarships Dictionary Visa Details Study Abroad Exam Results Online Test Jobs

	Home
Drug Discovery and Drug Designing Drug Discovery and Drug Designing Introduction Early History of Drug Discovery History of Drug Discovery Enzymes/Receptors as Drug Targets Receptors as Drug Targets Enzymes as Drug Targets Molecular Biology for Drug Discovery Recombinant Proteins and Monoclonal Antibodies as Drugs Molecular basis of Disease Processes Target Identification and Validation Combinatorial Chemistry and HTS Organic Synthesis (Combinatorial Chemistry for Drug Discovery) Target-Oriented Organic Synthesis and Retrosynthetic Analysis

Home >> Industrial and Microbial Biotechnology >>Drug Discovery and Drug Designing >> Genomics Drugs Pharmacogenomics

‘Genomics’ Drugs (Pharmacogenomics)

Drug discovery in the 21st century will also have to respond to the concept of pharmacogenimcs, which requires that for the same disease different drugs need to be prescribed, keeping in view the patient’s response to individual drugs. This aspect was discussed in some detail. This area of drug development will also be facilitated by e-cell simulation of causal and temporal behaviour of the cell as a network of genes and genes products. Such an ‘e-cell’ project is being used in Japan. Which reports simulation of a set of metabolic pathways in a cell that takes up glucose and excretes lactase. This area of research and its use in drug discovery will expand in future. Although ‘genomics’ drugs may take time to come to the markets, prognostic genotyping and diagnostic molecular profiling will certainly be used in routine medical practice in not too distant a future

Impact of Genomics and Computational technologies on pharmaceutical R & D and personalized patient health care

	Home
Diversity-Oriented Organic Synthesis and Evolving Synthetic Analysis Solid Phase Synthesis for Drug Discovery Combinatorial Biocatalysis for Drug Disovery Synthesis of Bergenin Derivatives Drug Discovery in Cancer Research Microbial Genomics for New Antibiotics Genomics Drugs (Pharmacogenomics) Immunotoxins as Drugs Drug Designing Drug Designing by Blocking Enzyme Activity Drug Designing through Blocking Hormone Receptors Drug Designing through Inhibition of Nucleic Acid Synthesis Drug Designing Against Heterogeneous Targets

Language >> English | Français | Español | Deutsch | Italiano | Portugues | Japanese | Korean | Sim-Chinese